The invention provides anti-apoptotic compositions lysophosphatidic acids and
methods for making and using the compositions. Such compositions can also contain
LPA potentiating agents, including proteins, lipid membrane structures and polymers
such as polyethylene glycols. The compositions can additionally contain other pharmaceutically
effective agents such as drugs, antibiotics, wound healing agents and antioxidants.